Free Trial

Oncology Pharma (ONPH) Short Interest Ratio & Short Volume

Oncology Pharma Short Interest Data

Current Short Interest
13,500 shares
Previous Short Interest
13,500 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$0.00
Short Interest Ratio
1.5 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
38,660,000 shares
Percentage of Shares Shorted
0.03%
Today's Trading Volume
463 shares
Average Trading Volume
3,788 shares
Today's Volume Vs. Average
12%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Oncology Pharma ?

Sign up to receive the latest short interest report for Oncology Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ONPH Short Interest Over Time

ONPH Days to Cover Over Time

ONPH Percentage of Float Shorted Over Time

Oncology Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202413,500 shares $0.00 No ChangeN/A1.5 $0.00
4/15/202413,500 shares $135.00 No ChangeN/A1.2 $0.01
3/31/202413,500 shares $1.35 No ChangeN/A4.5 $0.00
3/15/202413,500 shares $0.00 -0.7%N/A1.7 $0.00
2/29/202413,600 shares $0.00 No ChangeN/A2.4 $0.00
2/15/202413,600 shares $0.00 No ChangeN/A2.7 $0.00
1/15/202413,600 shares $0.00 No ChangeN/A3 $0.00
12/31/202313,600 shares $2.72 -4.9%N/A0.1 $0.00
12/15/202314,300 shares $2.86 -10.1%N/A0.3 $0.00
11/30/202315,900 shares $15.90 -52.0%N/A1 $0.00
11/15/202333,100 shares $33.10 -32.2%N/A2.7 $0.00
10/31/202348,800 shares $976.00 -17.2%N/A10 $0.02
10/15/202358,900 shares $2,208.75 -35.5%N/A6.5 $0.04
9/30/202391,300 shares $5,934.50 -1.0%N/A13.8 $0.07
9/15/202392,200 shares $4,378.58 -1.4%N/A10.5 $0.05
8/31/202393,500 shares $2,337.50 +523.3%N/A4.3 $0.03
8/15/202315,000 shares $4,275.00 -6.8%N/A0.2 $0.29
7/31/202316,100 shares $5,726.77 +16.7%N/A0.3 $0.36
7/15/202313,800 shares $5,422.02 -21.1%N/A0.3 $0.39
6/30/202317,500 shares $5,600.00 +19.9%N/A0.1 $0.32
6/15/202314,600 shares $8,176.00 -3.3%N/A0 $0.56
5/31/202315,100 shares $2,114.00 -22.6%N/A0.1 $0.14
5/15/202319,500 shares $2,730.00 +20.4%N/A0.1 $0.14
4/30/202316,200 shares $2,592.00 -30.5%N/A0.1 $0.16
4/15/202323,300 shares $3,902.75 -14.7%N/A0.2 $0.17
3/31/202327,300 shares $5,050.50 +45.2%N/A0.1 $0.19
3/15/202318,800 shares $5,452.00 -25.1%N/A0.2 $0.29
2/28/202325,100 shares $9,086.20 +9.6%N/A0.4 $0.36
2/15/202322,900 shares $8,702.00 -24.7%N/A0.2 $0.38
1/31/202330,400 shares $11,704.00 +28.8%N/A0.3 $0.39
1/15/202323,600 shares $9,676.00 -32.2%N/A0.1 $0.41
12/30/202234,800 shares $11,781.89 +5.1%N/A0.1 $0.34
12/15/202233,100 shares $16,881.00 -3.2%N/A0.2 $0.51
11/30/202234,200 shares $24,538.50 -6.8%N/A0.6 $0.72
11/15/202236,700 shares $34,131.00 -35.8%N/A0.2 $0.93
10/31/202257,200 shares $50,845.08 -5.9%N/A0.5 $0.89
10/15/202260,800 shares $26,144.00 -60.2%N/A0.4 $0.43
9/30/2022152,700 shares $70,242.00 +2.9%N/A1 $0.46
9/15/2022148,400 shares $129,093.16 +1.0%N/A2.5 $0.87
8/31/2022146,900 shares $149,838.00 -0.2%N/A1.6 $1.02
Musk, Bezos, and Gates All On Board… (Ad)

Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.

To get all the details of this controversial tech – click here now.
8/15/2022147,200 shares $198,720.00 -14.6%N/A1.3 $1.35
7/31/2022172,400 shares $231,016.00 -6.7%N/A1.1 $1.34
7/15/2022184,700 shares $265,968.00 -33.3%N/A1.2 $1.44
6/30/2022276,800 shares $405,788.80 -4.2%N/A3.7 $1.47
6/15/2022288,900 shares $433,350.00 -28.2%N/A1.8 $1.50
5/31/2022402,600 shares $805,200.00 -3.3%N/A4.3 $2.00
5/15/2022416,300 shares $865,279.55 -3.8%N/A2.8 $2.08
4/30/2022432,500 shares $1.28 million -1.0%N/A4.2 $2.96
4/15/2022437,000 shares $1.56 million +1.8%N/A4.2 $3.57
3/31/2022429,400 shares $1.59 million -16.6%N/A3 $3.70
3/15/2022515,000 shares $2.11 million -4.8%N/A1.6 $4.10
2/28/2022541,000 shares $2.75 million -4.0%N/A1 $5.08
2/15/2022563,400 shares $3.61 million +41.1%N/A1.2 $6.41
1/31/2022399,400 shares $1.34 million +4.0%N/A3.4 $3.36
1/15/2022384,100 shares $1.43 million -9.3%N/A1.4 $3.72
12/31/2021423,300 shares $1.71 million +5.4%N/A0.8 $4.05
12/15/2021401,700 shares $1.27 million +25.2%N/A0.8 $3.15
11/30/2021320,800 shares $1.75 million +4.8%N/A0.9 $5.44
11/15/2021306,200 shares $2.50 million -18.1%N/A0.4 $8.15
10/29/2021373,800 shares $4.68 million -9.8%N/A0.4 $12.52
10/15/2021414,600 shares $5.78 million +37.7%N/A0.5 $13.95
9/30/2021301,200 shares $3.26 million +78.0%N/A0.7 $10.82
9/15/2021169,200 shares $2.29 million +3.2%N/A0.4 $13.53
8/31/2021164,000 shares $3.15 million +98.6%N/A0.4 $19.20
8/13/202182,600 shares $1.68 million +32.2%N/A0.2 $20.30
7/30/202162,500 shares $1.39 million +79.1%N/A0.1 $22.17
7/15/202134,900 shares $731,155.00 +160.5%N/A0.1 $20.95
6/30/202113,400 shares $0.00 -82.2%N/A0 $0.00

ONPH Short Interest - Frequently Asked Questions

What is Oncology Pharma's current short interest?

Short interest is the volume of Oncology Pharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 13,500 shares of ONPH short. Learn More on Oncology Pharma's current short interest.

What is a good short interest ratio for Oncology Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONPH shares currently have a short interest ratio of 2.0. Learn More on Oncology Pharma's short interest ratio.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Oncology Pharma stock?

Short selling ONPH is an investing strategy that aims to generate trading profit from Oncology Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oncology Pharma?

A short squeeze for Oncology Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONPH, which in turn drives the price of the stock up even further.

How often is Oncology Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONPH, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:ONPH) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners